Allena Pharmaceuticals (ALNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALNA Annual Balance Sheets →
The balance sheet data below highlights changes in Allena Pharmaceuticals's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2022)
(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Assets
Cash & cash equivalent6.59
Cash & Short-term Investments6.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.90
Total Current Assets16.49
Equipment/Property/Plant Net0.93
Other Assets, Noncurrent0.40
Operating Lease Right Of Use Asset0.27
Total Assets17.81
Liabilities
Accounts Payable, Current AC2.27
Accrued Liabilities, Current AC2.87
Loans Payable, Current NO4.90
Total Current Liabilities10.43
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE3.65
Operating Lease Liability Current0.38
Operating Lease Liability Noncurrent-
Total Liabilities14.07
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock270.33
Retained Earnings / Accumulated Deficit-266.70
Other Equity0.00
Common Stockholder's Equity3.74
Total Stockholder's Equity3.74
Liabilities & Stockholder's Equity17.81
4 historic quarters locked

Sign in to unlock the full Allena Pharmaceuticals balance sheet history.

About Allena Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-22-017398

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.